Prometheus ruling in US provides relief, but other cases may be vexing
This article was originally published in RAJ Devices
Executive Summary
Drug and diagnostic developers breathed a sigh of relief after the US Court of Appeals for the Federal Circuit ruled that a test used to determine proper drug dosing is patentable1.